Vasomedical

What Vasomedical does

Vasomedical, a privately held US medical device company incorporated as Vaso Corporation and headquartered in Plainview, New York, operates two complementary cardiovascular product lines targeted at hospitals, cardiology practices, IDTFs, and high-volume ECG monitoring centers. Its diagnostics business is the ARCS Cloud platform — a cloud-native, device-agnostic cardiac monitoring system that unifies Holter, Extended Holter, Event, and Mobile Cardiac Telemetry (MCT) workflows from intake through final report, supported by FDA-cleared algorithms that reduce ECG artifacts and shorten scan times. The platform accepts data from the company's own BIOX ambulatory recorders (Holter, ABPM, and 2-in-1 ECG/ABPM devices, manufactured through the wholly-owned Biox Instruments subsidiary in China) as well as third-party patches from partners Wellysis and Vivalink, deliberately avoiding closed hardware lock-in.

The company's therapy business centers on Enhanced External Counterpulsation (EECP) systems sold under the Lumenair brand — a non-invasive cardiovascular treatment deployed in 600+ clinics across 40+ countries. To address chronically underutilized installed EECP bases, VasoMedical has built the Advanced Cardiac Therapy (ACT) Program, a consultative service offering that pairs equipment with referral frameworks, defined ownership structures across cardiology and rehab, and utilization tracking — effectively positioning EECP as a managed service line rather than a piece of hardware.

The business model blends three revenue streams: subscription-based ARCS Cloud SaaS pricing (annual billing, quote-based enterprise pricing), hardware sales of EECP systems and BIOX recorders (both US and international channels), and professional services tied to ACT program implementation and ongoing optimization. Go-to-market is sales-led and event-driven, centered on a direct field and inside sales organization, toll-free/direct phone outreach, dedicated sales and marketing leadership (Director of Sales and Marketing, VP of Operations), and a heavy conference presence anchored by the Heart Rhythm Society Scientific Sessions (Booth #1624 at HRS 2026). The company has been operating since 1995, transitioned to a SaaS model in 2021, and remains management-controlled without disclosed institutional or venture funding.

Name

Vasomedical

Legal name

Vaso Corporation

Website

https://vasomedical.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

101–250 employees

Short description

VasoMedical (Vaso Corporation) is a privately held US medical device company that sells the ARCS Cloud cardiac monitoring SaaS platform, EECP non-invasive cardiovascular therapy systems, and BIOX ambulatory ECG and blood pressure recorders to hospitals, cardiology practices, and IDTFs across 40+ countries.

Ownership category

akta.pro rank

Product category

Cardiovascular Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)

akta.pro secondary industries

Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL), Mechanical Circulatory Support (VAD, IABP, ECMO) (HLAHAFAG), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

• Cardiac monitoring systems
• Medical device manufacturing
• EECP therapy systems
• Ambulatory ECG monitoring
• Cardiac diagnostic platforms

Headquarters

HQ city

Plainview

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. ARCS Cloud Subscriptions: Subscription-based ECG and blood pressure analysis and reporting through the ARCS Cloud SaaS platform. The platform supports high-volume cardiac monitoring operations on a recurring subscription basis.
2. EECP Therapy Systems: Sale and servicing of EECP (Enhanced External Counterpulsation) therapy systems for non-invasive cardiovascular treatment. Both domestic US and international sales channels are active.
3. BIOX Ambulatory Monitors: Sale of ambulatory ECG and blood pressure monitoring hardware including Holter recorders, ABPM devices, and combined ECG/ABPM units. Hardware is sold directly and is fully integrated with the ARCS Cloud platform.
4. ACT Program Services: Program design, implementation support, and ongoing partnership services for hospitals and clinics adopting EECP via the Advanced Cardiac Therapy (ACT) program model, including operational consulting and utilization optimization.
5. International Sales & Servicing: International sales and servicing of EECP therapy systems and BIOX ambulatory monitoring devices, with a global footprint spanning 40+ countries.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Vasomedical designs, manufactures, and sells cardiovascular medical devices and a cloud-based cardiac monitoring platform. Its portfolio centers on the Lumenair EECP (Enhanced External Counterpulsation) therapy system for non-invasive cardiovascular treatment and the ARCS Cloud platform for high-volume ambulatory ECG analysis (Holter, Extended Holter, Event, and MCT studies), supplemented by BIOX ambulatory ECG and blood-pressure recorders and the Advanced Cardiac Therapy (ACT) program.

Product overview

Vasomedical offers a unified cardiac care portfolio centered on two core offerings: the ARCS Cloud platform for cloud-based cardiac monitoring and analysis, and EECP (Enhanced External Counterpulsation) therapy systems for non-invasive cardiovascular treatment. The ARCS Cloud platform supports the full review lifecycle for Holter, Extended Holter, Event, and MCT studies with algorithm-assisted workflows. The EECP division provides therapy systems through the Lumenair brand, supported by the Advanced Cardiac Therapy (ACT) Program for operational enablement. Ambulatory monitoring is supported through the BIOX recorder product line (Holter, ABPM, and combination ECG/ABPM devices) and compatibility with third-party patches including Wellysis S-Patch and Vivalink. The portfolio spans diagnostic monitoring, therapeutic intervention, and operational support services for cardiology practices, hospitals, and independent diagnostic testing facilities (IDTFs).

Differentiator

Problem solved

Functional benefit

Products and services

• ARCS Cloud A cloud-native cardiac monitoring platform for high-volume ECG operations, supporting Holter, Extended Holter, Event, and MCT studies with FDA-cleared algorithm-assisted review and unified reporting workflows. Sold on a subscription basis to IDTFs, cardiology groups, and hospital service lines.
• Lumenair EECP Therapy System Non-invasive Enhanced External Counterpulsation therapy systems for cardiovascular treatment, deployed in 600+ clinics across 40+ countries. Sold to hospitals, cardiology practices, and outpatient service lines.
• Advanced Cardiac Therapy (ACT) Program A program design and ongoing partnership service for hospitals and clinics that establishes referral frameworks, defined ownership across cardiology, rehab, and administration, and utilization tracking to move EECP from equipment-only purchase to a complete clinical service line.
• BIOX Holter Recorder Clinical-grade ambulatory ECG Holter recorder for daily-volume cardiac monitoring with proven signal quality and simple patient setup, integrated with the ARCS Cloud platform.
• BIOX ABPM Recorder Ambulatory blood pressure monitor providing 48-hour BP profiles with patient-friendly wear and reliable clinical data, integrated with the ARCS Cloud platform.
• BIOX ECG & ABPM Combined Recorder Combined ECG and ambulatory blood pressure monitor in a single device, reducing device swaps and simplifying workflow for staff and patients, integrated with the ARCS Cloud platform.

Quantifiable outcome

• Reduce artifacts and shorten scan times with FDA-cleared algorithms
• +6 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature9 records

Partnerships

Two partnerships are on record, tiered core.

• WellysiscoreTechnology or IntegrationWellysis is a device integration partner whose S-Patch ECG monitoring patch is fully supported within the ARCS Cloud platform. The partnership provides ARCS customers with extended-wear, high patient compliance ECG monitoring without requiring them to operate in a closed hardware ecosystem. Wellysis appears in both the technology integrations section (Devices page) and the customer logos section of the VasoMedical website.
• VivalinkcoreTechnology or IntegrationVivalink provides flexible, clinical-grade ECG monitoring patches for extended arrhythmia monitoring. The Vivalink patch integrates directly into ARCS Cloud workflows without proprietary lock-in, enabling ARCS customers to deploy Vivalink devices for MCT and extended Holter studies within the same unified platform. The partnership supports scalability and clinical-grade data quality.

Scale indicators7 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• iRhythm Technologies: iRhythm's Zio long-term continuous monitoring patch and cloud-based ECG analytics platform directly competes with ARCS Cloud for high-volume ambulatory cardiac monitoring at IDTFs and cardiology practices.
• Preventice Solutions (Boston Scientific): Preventice's BodyGuardian suite of MCT and Event monitors, now part of Boston Scientific, competes with ARCS Cloud across mobile cardiac telemetry and ambulatory ECG workflows.
• Biotricity: Biotricity offers cloud-connected remote cardiac monitoring (Bioflux MCT) for IDTFs and cardiologists, overlapping directly with ARCS Cloud's MCT and Holter study workflows.
• ScottCare Cardiovascular Solutions: ScottCare provides Holter analysis systems, event monitoring, and cardiopulmonary rehabilitation platforms, making it a direct peer in both ambulatory ECG and cardiac rehab/EECP-adjacent service lines.

Broad incumbents

• Philips (BioTelemetry legacy): Philips acquired BioTelemetry to become a dominant ambulatory cardiac monitoring incumbent; its MCT, Event, and Holter services compete with ARCS Cloud across enterprise health systems.
• GE Healthcare (MUSE & ECG portfolio): GE Healthcare's MUSE cardiology information system and resting ECG/Holter portfolio competes broadly with ARCS Cloud in hospital and IDN environments, especially for ECG management workflows.
• Hillrom / Baxter (Welch Allyn, Mortara): Hillrom/Baxter's Mortara and Welch Allyn ECG/Holter hardware and middleware compete with BIOX devices and the device-agnostic integrations ARCS Cloud relies upon.

Regional players

• Schiller AG: Schiller manufactures Holter recorders, ECG carts, and stress-test systems with strong international presence (especially Europe), competing with BIOX devices in markets outside North America.

Emerging players

• Wellysis: Wellysis is a Korean-based ECG patch maker whose S-Patch integrates with ARCS Cloud; it represents the emerging patch-form-factor peer category that ARCS Cloud is positioning to support rather than compete against.
• Vivalink: Vivalink provides clinical-grade ECG patches for extended arrhythmia monitoring and is integrated into ARCS Cloud; as an emerging cardiac patch vendor it is both a partner and adjacent competitor in ambulatory monitoring.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/vasomedical
• Facebookfacebook.com/vasomedical
• LinkedInlinkedin.com/company/vasomedical-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vasomedical